These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1902490)

  • 1. Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edema.
    Kramer J; Katz Y; Rosen FS; Davis AE; Strunk RC
    J Clin Invest; 1991 May; 87(5):1614-20. PubMed ID: 1902490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transinhibition of C1 inhibitor synthesis in type I hereditary angioneurotic edema.
    Kramer J; Rosen FS; Colten HR; Rajczy K; Strunk RC
    J Clin Invest; 1993 Mar; 91(3):1258-62. PubMed ID: 8450054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for the deficiency of complement 1 inhibitor in type I hereditary angioneurotic edema.
    Cicardi M; Igarashi T; Rosen FS; Davis AE
    J Clin Invest; 1987 Mar; 79(3):698-702. PubMed ID: 3818946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema.
    Quastel M; Harrison R; Cicardi M; Alper CA; Rosen FS
    J Clin Invest; 1983 Apr; 71(4):1041-6. PubMed ID: 6833491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema.
    Cugno M; Nuijens J; Hack E; Eerenberg A; Frangi D; Agostoni A; Cicardi M
    J Clin Invest; 1990 Apr; 85(4):1215-20. PubMed ID: 2318974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary and acquired deficiencies of C1 inhibitor.
    Davis AE
    Immunodefic Rev; 1989; 1(3):207-26. PubMed ID: 2698641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in purified dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema. Functional and analytical gel studies.
    Donaldson VH; Harrison RA; Rosen FS; Bing DH; Kindness G; Canar J; Wagner CJ; Awad S
    J Clin Invest; 1985 Jan; 75(1):124-32. PubMed ID: 3965500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1-inhibitor--biochemical properties and clinical applications.
    Al-Abdullah IH; Greally J
    Crit Rev Immunol; 1985; 5(4):317-30. PubMed ID: 3899511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restriction fragment length polymorphism of the C1 inhibitor gene in hereditary angioneurotic edema.
    Cicardi M; Igarashi T; Kim MS; Frangi D; Agostoni A; Davis AE
    J Clin Invest; 1987 Dec; 80(6):1640-3. PubMed ID: 2890659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of plasma kallikrein and C1-s with normal and dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema: analytic gel studies.
    Donaldson VH; Wagner CJ; Tsuei B; Kindness G; Bing DH; Harrison RA; Rosen FS
    Blood; 1987 Apr; 69(4):1096-101. PubMed ID: 3493816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte C1-inhibitor synthesis in patients with C1-inhibitor deficiency.
    Lappin DF; McPhaden AR; Yap PL; Carter PE; Birnie GD; Fothergill JE; Whaley K
    Eur J Clin Invest; 1989 Feb; 19(1):45-52. PubMed ID: 2499461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remissions induced in hereditary angioneurotic edema with an attenuated androgen (danazol): correlation between concentrations of C1-inhibitor and the forth and second components of complement.
    Pitts JS; Donaldson VH; Forristal J; Wyatt RJ
    J Lab Clin Med; 1978 Oct; 92(4):501-7. PubMed ID: 712189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of C1-inhibitor synthesis by interferons and other agents.
    Lappin D; Whaley K
    Behring Inst Mitt; 1989 Jul; (84):180-92. PubMed ID: 2478116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
    Katz Y; Strunk RC
    J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of C1 inhibitor synthesis.
    Prada AE; Zahedi K; Davis AE
    Immunobiology; 1998 Aug; 199(2):377-88. PubMed ID: 9777421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C1 inhibitor gene expression in patients with hereditary angioedema: quantitative evaluation by means of real-time RT-PCR.
    Pappalardo E; Zingale LC; Cicardi M
    J Allergy Clin Immunol; 2004 Sep; 114(3):638-44. PubMed ID: 15356570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired production of both normal and mutant C1 inhibitor proteins in type I hereditary angioedema with a duplication in exon 8.
    Ernst SC; Circolo A; Davis AE; Gheesling-Mullis K; Fliesler M; Strunk RC
    J Immunol; 1996 Jul; 157(1):405-10. PubMed ID: 8683145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1 esterase inhibitor gene expression in rat Kupffer cells, peritoneal macrophages and blood monocytes: modulation by interferon gamma.
    Armbrust T; Schwögler S; Zöhrens G; Ramadori G
    J Exp Med; 1993 Aug; 178(2):373-80. PubMed ID: 8340749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary angioneurotic oedema in Finland. Clinical, immunological and genealogical studies.
    Ohela K
    Acta Med Scand; 1977; 201(5):415-27. PubMed ID: 899863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid method for functional determination of C1 esterase inhibitor in plasma.
    Cullmann W; Kövary PM; Dick W; Czarnetzki B; Echternach-Happle K
    Clin Chim Acta; 1982 Mar; 119(3):237-42. PubMed ID: 6175450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.